Fig. 4From: Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison studySurveyed pain distribution. Subject reported pain levels while using the TAP II Device on the NRS-11, a 0–10 pain scale with associated benchmarks to help respondents identify their relative levels of painBack to article page